Hollow fiber membrane and method for manufacturing thereof

Details for Australian Patent Application No. 2007312413 (hide)

Owner GAMBRO LUNDIA AB

Inventors Krause, Bernd; Goehl, Hermann; Hornung, Markus; Kraft, Carina

Agent Griffith Hack

Pub. Number AU-B-2007312413

PCT Pub. Number WO2008/046779

Priority 60/829,965 18.10.06 US; 0602189-3 18.10.06 SE

Filing date 11 October 2007

Wipo publication date 24 April 2008

Acceptance publication date 29 September 2011

International Classifications

B01D 69/02 (2006.01) Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties

B01D 69/08 (2006.01) Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties

B01D 71/68 (2006.01) Semi-permeable membranes for separation processes or apparatus characterised by the material

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/046779 Priority application(s): WO2008/046779

26 March 2009 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read from Gohl, Hermann to Goehl, Hermann

2 April 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 20 Feb 2009

29 September 2011 Application Accepted

  Published as AU-B-2007312413

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007312415-Method and means for producing a magnetically induced indicia in a coating containing magnetic particles

2007312391-Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes